Jeffrey Cleland is the founder of Ashvattha Therapeutics. Latest round: Series B. Backed by Tribe Capital, Arjun Sethi. Based in San Mateo, California.
Jeffrey L. Cleland, PhD, is the President and CEO of Ashvattha Therapeutics, a biotechnology company focused on nanomedicine therapies for ocular diseases. He has significant startup experience, having secured over $500 million in capital across various funding stages, including an IPO exit.
Full founder directory · Investor directory · Company funding database · Fundraising library